newsfilter
← Latest News
GlobeNewswire·

Cellect Biotechnology Initiates U.S. Clinical Trial of ApoGraft

Tel Aviv, Israel , Oct. 22, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology which enables the functional selection of cells facilitating...